Cardiac metabolomics stands at the forefront of scientific inquiry, delving into the intricate world of small molecules governing the metabolic intricacies within the heart. This emerging discipline employs advanced analytical techniques to comprehensively explore the dynamic landscape of metabolites, unraveling the complex web of metabolic pathways in the cardiovascular system. By deciphering the nuanced changes in metabolite profiles, researchers aim to uncover the molecular underpinnings of cardiac health and disease. This profound understanding has the potential to revolutionize diagnostic approaches and therapeutic strategies, offering a unique perspective on personalized medicine in the realm of cardiovascular care. In the realm of cardiac metabolomics, scientists strive to identify distinctive metabolic signatures linked to various cardiac conditions, paving the way for tailored interventions and enhancing our ability to precisely detect, monitor, and treat cardiovascular diseases.
Title : Revolutionizing CKD care: How finerenone transforms outcomes in heart and kidney health - Insights from fidelio-DKD
Robert J Chilton, University of Texas Health Science Center San Antonio, United States
Title : Novel important cellular responses, signaling mechanisms and therapeutic options for pulmonary hypertension and right heart failure
Yong Xiao Wang, Albany Medical Center, United States
Title : Preventing sports-related cardiac arrest: Coronary artery calcium scoring stratifies the benefit of low-dose aspirin use for risk reduction
Arthur J Siegel, Massachusetts General Hospital, United States
Title : Empathy and precision: Revolutionizing communication between cardiologists and patients
Iris Panagiota Efthymiou, University of Greenwich, United Kingdom
Title : Post-cardiotomy ECMO (PC-ECMO)
Gustavo Lionel Knop, Mayo Clinic, United States
Title : The past, present and future of AI in cardiology
Narendra Kumar, HeartbeatsZ Academy, United Kingdom